These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1958434)

  • 1. Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients.
    Agheli N; Jacotot B
    Br J Clin Pharmacol; 1991 Oct; 32(4):423-8. PubMed ID: 1958434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Stohler R; Keller U; Riesen WF
    Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary treatment on the lipid, lipoprotein and fatty acid compositions in type IV familial hypertriglyceridemia.
    Agheli N; Cloarec M; Jacotot B
    Ann Nutr Metab; 1991; 35(5):261-73. PubMed ID: 1776822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia.
    Bard JM; Luc G; Douste-Blazy P; Drouin P; Ziegler O; Jacotot B; Dachet C; De Gennes JL; Fruchart JC
    Eur J Clin Pharmacol; 1989; 37(6):545-50. PubMed ID: 2693115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
    Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome.
    Vega GL; Ma PT; Cater NB; Filipchuk N; Meguro S; Garcia-Garcia AB; Grundy SM
    Am J Cardiol; 2003 Apr; 91(8):956-60. PubMed ID: 12686335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin on the number and composition of apoproteinB-containing lipoproteins in hypercholesterolemia: analysis of apoproteinB in each lipoprotein fraction by highly sensitive latex method.
    Ikeda Ryomoto K; Suzuki M; Tsushima M; Yamamoto A; Harano Y
    Endocr J; 1996 Oct; 43(5):469-75. PubMed ID: 8980885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.
    Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M; Bonnefous F; Debbas N; Irvine A
    Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.
    Mitropoulos KA; Armitage JM; Collins R; Meade TW; Reeves BE; Wallendszus KR; Wilson SS; Lawson A; Peto R
    Eur Heart J; 1997 Feb; 18(2):235-41. PubMed ID: 9043839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol. Reduction of the proportion of linoleate by clofibrate but not by niceritrol.
    Vessby B; Lithell H; Gustafsson IB; Boberg J
    Atherosclerosis; 1980 Jan; 35(1):51-65. PubMed ID: 6989377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein particle analysis comparing simvastatin and fenofibrate.
    Bard JM; Parra HJ; Luc G; Camare R; Ziegler O; Dachet C; Bruckert E; Douste-Blazy P; Drouin P; Jacotot B
    Atherosclerosis; 1991 Dec; 91 Suppl():S29-34. PubMed ID: 1789814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simvastatin on qualitative and quantitative changes of lipoprotein metabolism in CAPD patients.
    Wanner C; Lubrich-Birkner I; Summ O; Wieland H; Schollmeyer P
    Nephron; 1992; 62(1):40-6. PubMed ID: 1436290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy and tolerance of simvastatin and fenofibrate in primary hypercholesterolemia].
    Fricker J; Douste-Blazy P; Drouin P; De Gennes JL; Dachet C; Keller U
    Presse Med; 1990 Dec; 19(42):1927-30. PubMed ID: 2147752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDL composition and angiographically determined progression of atherosclerotic lesions during simvastatin therapy.
    Sutherland WH; Restieaux NJ; Nye ER; Williams MJ; de Jong SA; Robertson MC; Walker HL
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):577-83. PubMed ID: 9555863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.